Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Carcinoma, Non-Small-Cell Lung 2Pancreatic Neoplasms 1Malnutrition 1Lung Neoplasms 1Head and Neck Neoplasms 1Depression 1Anorexia 1

Interventions

Psychiatric Rehabilitation 4Educational Status 2Early Intervention, Educational 2Cognitive Behavioral Therapy 2Yoga 1Vitamin E 1Uncertainty 1Surveys and Questionnaires 1Psychotherapy 1Psychosocial Intervention 1Mirtazapine 1Mindfulness-Based Stress Reduction 1Methods 1Meditation 1Massage 1Interviews as Topic 1Gemcitabine 1Fluoxetine 1Exercise Therapy 1Escitalopram 1Donepezil 1Counseling 1Cisplatin 1Caregivers 1Behavior Therapy 1Analgesia 1Acceptance and Commitment Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Depression × Mirtazapine × Thoracic × Clear all
NCT02650544 2016-01-08

Efficacy and Safety Analyses of Mirtazapine in NSCLC Patients With Depression

Sun Yat-sen University

Phase 2 Unknown
236 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Depression

Data powered by HemOnc (CC BY 4.0) Colophon âš¡